z-logo
open-access-imgOpen Access
Piperacillin-lnduced Acute Interstitial Nephritis
Author(s) -
Juan I. Soto,
J. M. Bosch,
Alsar Ortiz,
M.J. Moreno,
Juan D. González,
José María Díaz Fernández
Publication year - 1993
Publication title -
˜the œnephron journals/nephron journals
Language(s) - English
Resource type - Journals
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000187461
Subject(s) - medicine , nephritis , interstitial nephritis , dermatology , nephrology , pathology , gastroenterology , kidney
Piperacillin-lnduced Acute Interstitial Nephritis J. Soto J.M. Bosch M.J.A. Alsar Ortiz M.J. Moreno J.D. Gonzalez J.M. Diaz Clinical Pharmacology Unit, Hospital Santa Cruz, Liencres-Cantabria; Hematology Service, Hospital Insular, Las Palmas de Gran Canaria, Spain Maria J. Alsar Ortiz, /Floranes, 48-1°D, E-39010 Santander, Cantabria (Spain) Dear Sir, Acute interstitial nephritis (AIN) has been well documented during therapy with antimicrobial agents of the penicillin class, including penicillin G [1], ampicillin [2], oxacil-lin [3], methicillin [4], nafcillin [5], carbenicil-lin [6] and mezlocillin [7]. Piperacillin is a semisynthetic penicillin with activity against Pseudomonas aerugi-nosa, other gram-negative bacteria and some gram-positive bacteria, which has been available commercially in a great number of countries for long time. Despite a worldwide clinical experience, however, AIN associated with piperacillin has been reported just once [8]. Here we describe a patient with probably clinical AIN in association with piperacillin therapy. A 59-year-old man was admitted to our hospital for acute nonlymphoblastic leukemia (M2 of the FAB classification). His induction treatment was done with Adriamycin (30 mg/m2 i.v. for 3 days) and cytarabine (1 g/l2 h/m2 for 3 days plus 100 mg/m2 for 7 days). Allopurinol (200 mg/day) was added to the treatment. He had no history of drug reaction or allergies. Two months later, the patient presented fever and pulmonary infiltrates in a chest X-ray, which were treated with antibiotics (vancomycin: 500 mg/6 h, amikacin: 500 mg/ 12 h, imipenem: 500 mg/6 h) and amphotericin B (30 mg/day). Ten days later the infiltrates and fever persisted unchanged. As we suspected tuberculous infection, antibiotics and amphotericin B were discontinued, and rifampicin (600 mg/day), isoniazid (300 mg/day), ethambutol (1,200 mg/day) and py-razinamide (1750 mg/day) were instituted, with good response, and the fever and the infiltrates disappeared. At this time his blood urea nitrogen (BUN) and serum creatinine levels were 56 mg/dl (19.9 mmol/l) and 2.3 mg/dl (203.3 μmol/l), respectively, the rest of laboratory data being normal [except an uric acid level of 13.4 mg/dl (0.79 mmol/l)]. The hemogram showed a normal number of leukocytes, neu-trophils and red blood cells. The platelet count was 30,000/μl, and urinalysis was normal without hematuria and eosinophils. Two weeks later, the patient developed fever again, since Acinetobacteranitratusgτew from blood cultures. The patient was given intravenous piperacillin (4 g every 6 h), because the germ was sensible to this antibiotic. The rest of the medication was not changed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom